The NUTRIOME Study - a Data-driven Precision Nutrition Intervention
NCT ID: NCT06842433
Last Updated: 2025-03-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
120 participants
INTERVENTIONAL
2025-03-14
2026-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
A total of 120 men and women who meet all inclusion criteria and none of the exclusion criteria will be invited to participate. The study will be conducted at three sites: Chalmers University of Technology (Sweden), University of Wageningen (Netherlands), and University of Oslo (Norway), with 40 participants per site.The study is conducted in two parts. The first part, the characterization phase, is a three-way randomized, controlled cross-over design, featuring one-day meal tests with isocaloric meals containing different carbohydrate, fat and protein quantity as well as quality. Based on the metabolic response to the meal tests a personalized diet will be constructed. In the second part, the main intervention, effectiveness of this personalized dietary advice compared to a general healthy diet will be tested in a six week parallel group intervention study.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Targeted Precision Nutrition Strategy To Prevent Chronic Metabolic Diseases
NCT06923644
Study of the Potential of a Macronutrient Balanced Normocaloric Diet to Treat Lifestyle Diseases
NCT01278121
Challenges in Achieving Adequate Dietary Status of Women
NCT06745817
Nutrition for Precision Health, Powered by the All of Us
NCT05701657
Measuring Daily Grain Intake Study
NCT04104581
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
DOUBLE
Wherever possible Care providers and researchers conducting the analysis (e.g., nurses drawing blood samples) will be blinded to the allocation of intervention.
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
General healthy diet
General healthy diet based on national health dietary guidelines.
General healthy diet
General healthy diet based on national health dietary guidelines.
Personalized diet
Personalized diet will be based on an algorithm considering the individuals' postprandial glucose, triglycerides and inflammation markers to each of the three study meals in the characterization phase (Phase I) matched with established knowledge about the effects of specific foods on such metabolic parameters
Personalized diet
Personalized diet will be based on an algorithm considering the individuals' postprandial glucose, triglycerides and inflammation markers to each of the three study meals in the characterization phase (Phase I) matched with established knowledge about the effects of specific foods on such metabolic parameters.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
General healthy diet
General healthy diet based on national health dietary guidelines.
Personalized diet
Personalized diet will be based on an algorithm considering the individuals' postprandial glucose, triglycerides and inflammation markers to each of the three study meals in the characterization phase (Phase I) matched with established knowledge about the effects of specific foods on such metabolic parameters.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age 40 to 70 years
* Body mass index (BMI) 27-35 kg/m2
* Signed informed consent
Exclusion Criteria
* Diagnosed type 1 or type 2 diabetes
* Finger prick glucose test at screening indicating diabetes (fasting \>6.9 mmol/L; non-fasting \>11.0 mmol/L)
* Antibiotic use in the last 3 months
* Taking medication that can interfere with the planned outcome measures, as judged by the study physician (e.g. peroxisome proliferator-activated receptor-α \[PPAR-α\] or PPAR-γ agonists \[fibrates\], sulfonylureas, biguanides, α-glucosidase inhibitors, thiazolidinediones, repaglinide, nateglinide and insulin, chronic use of NSAIDs). Statins and hypertension medication are allowed if the medication regimen has been stable for the last three months
* Stomach and gastrointestinal conditions (e.g. Morbus Chron, Ulcerative colitis, irritable bowel syndrome, malabsorption, colostomy, bowel resection, gastric bypass surgery etc.)
* History of major gastrointestinal surgery
* Anaemia: Hb concentrations \< 8.5 mmol/L for men and \< 7.5 mmol/L for women
* Recent blood donation (within 2 months prior to the screening)
* Recent participation in another intervention study (within 2 months prior to the screening)
* Allergy or intolerance to medical skin adhesives
* Chronic or acute inflammatory conditions (e.g., rheumatoid arthritis, psoriatic arthritis)
* Autoimmune disorders
* Thyroid disorders
* Significant renal or liver dysfunction or chronic kidney or liver disease
* Known food allergies/intolerances to intervention foods or food products used in the study
* Following specific dietary regimen that could impact results or not suitable for the study design (e.g. vegetarian, vegan)
* Habitual tobacco consumption (e.g. smoking, use of snus, vaping)
* Alcohol intake ≥ 14 alcoholic beverages/week for women and ≥ 21 alcoholic beverages/week for men
* Current or planned pregnancy or lactating
* Other serious medical conditions that could interfere with participation or study outcomes
* Unable to sufficiently understand written and spoken national language (where the study centre is located) to provide written consent and understand information and instructions from the study personnel.
* Deemed unsuitable for participation in the trial, for any reason, as judged by the research physician or PI.
* Working at the division conducting the trial at any of the three study centres.
* Do not have a mobile phone that is suitable for the use of a research app.
40 Years
70 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Oslo
OTHER
Wageningen University
OTHER
Polish Academy of Sciences
OTHER
Maastricht University
OTHER
German Cancer Research Center
OTHER
University of Copenhagen
OTHER
University of Oulu
OTHER
University College Dublin
OTHER
Chalmers University of Technology
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Rikard Landberg
Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Wageningen University and Research, Human research unit
Wageningen, , Netherlands
Department of nutrition, University of Oslo
Oslo, , Norway
University of Gothenburg, Department of Internal medicin and Clinical nutrition
Gothenburg, , Sweden
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Nutriome
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.